Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vincent Medical HoldingsHKSE:01612 +1.43%49 Median PS Value is HK$1.13 as of Aug. 02, 2026, which is 100% below its 10-year median of 0.73. GuruFocus rates HKSE:01612 with a GF Score™ of 49/100 and a GF Value™ of HK$0.58 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 336 Medical Devices & Instruments companies, Vincent Medical Holdings ranks better than 60.12% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Vincent Medical Holdings's Median PS Value or its related term are showing as below:
HKSE:01612'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.61 Med: 0.73 Max: 0.73
Current: 0.63
During the past 13 years, the highest Price to Median PS Value of Vincent Medical Holdings was 0.73. The lowest was 0.61. And the median was 0.73.
HKSE:01612's Price-to-Median-PS-Value is ranked better than 60.12% of 336
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs HKSE:01612: 0.63
Vincent Medical Holdings (HKSE:01612) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Vincent Medical Holdings's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.71
/
1.13
=
0.63
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vincent Medical Holdings Median PS Value Related Terms
Vincent Medical Holdings Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01612 vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, Vincent Medical Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vincent Medical Holdings Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vincent Medical Holdings's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Vincent Medical Holdings's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.7891.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vincent Medical Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.432.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vincent Medical Holdings (HKSE:01612) has a Median PS Value of HK$1.13 as of Aug. 02, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Vincent Medical Holdings and its competitors. This is 55% above median its historical median of 0.73. Over the past decade, Vincent Medical Holdings' Median PS Value has ranged from 0.61 to 0.73. According to the industry distribution chart, Vincent Medical Holdings ranks #134 out of 336 companies in the Medical Devices & Instruments industry, placing it in the top 39.9%.
Is Vincent Medical Holdings' Median PS Value too high?
Vincent Medical Holdings' current Median PS Value of HK$1.13 is 55% above median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 0.73. Based on the distribution chart, Vincent Medical Holdings ranks #134 out of 336 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Vincent Medical Holdings has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vincent Medical Holdings' Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vincent Medical Holdings ranks #134 out of 336 companies for Median PS Value. This puts Vincent Medical Holdings in the upper half of its industry. The industry median Median PS Value is 0.71. Historically, Vincent Medical Holdings' own Median PS Value has ranged from 0.61 to 0.73 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Vincent Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vincent Medical Holdings's current Median PS Value is HK$1.13, which is 55% above median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vincent Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vincent Medical Holdings (HKSE:01612) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.58, compared to a current price of HK$0.71 — trading 22.4% above its estimated fair value. The current Median PS Value is HK$1.13, which is 55% above median its 10-year median of 0.73. Vincent Medical Holdings' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Vincent Medical Holdings (HKSE:01612), the current Median PS Value is HK$1.13 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vincent Medical Holdings (HKSE:01612) Overvalued in 2026?
Based on GuruFocus' analysis, Vincent Medical Holdings stock appears to be overvalued.
The current stock price of HK$0.71 is trading 22.4% above its estimated GF Value™ of HK$0.58.
GuruFocus considers Vincent Medical Holdings to be Modestly Overvalued.
Key valuation signals for HKSE:01612:
Median PS Value: HK$1.13 (55% above median its 10-year median of 0.73)
GF Value™: HK$0.58 vs. price of HK$0.71 (22.4% above fair value)
No single metric tells the full story. See the HKSE:01612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vincent Medical Holdings Ltd is an investment holding company engaged in the manufacturing and selling of medical devices focusing on imaging disposable products on an OEM basis to one of the world's diagnostic imaging solutions providers. The company operates in two segments: OEM (original equipment manufacturing) and OBM (original brand manufacturing). The OEM segment manufactures products as per the customer's requirements. The OBM segment includes research, development, manufacturing, marketing, and sales of medical devices under the Inspired Medical, and Hand of Hope brands. The geographical segments of the company includes the United States, Spain, the PRC, Japan, Costa Rica, the Netherlands, Germany, and Others. It derives its maximum revenue from Spain.
49GF Score
Get the complete analysis for HKSE:01612
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01612 has been successfully added to your 
